Online Education | Pediatric Drug Therapy 2018 | Drug Eruptions in the Pediatric Population
Is it a Drug Eruption? A Viral Exanthem? Graft vs. Host Disease? Yes!
Robert Sidbury, MD, MPH
Professor, Dept. of Pediatrics,
University of Washington School of Medicine;
Chief, Division of Dermatology,
Seattle Children's Hospital, Seattle, WA
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be able to:
- Review the differential diagnosis of fever and rash in kids. Discriminate benign from not benign.
- Contrast "urticaria multiforme" and erythema multiforme.
- Discuss life-threatening medication reactions.
- Highlight how medication reactions can be in the differential of child abuse.
Completion Requirements
- Watch or listen to the presentation.
- Submit an evaluation.
- Complete coursework by the expiration date (We'll remind you 60 days out.)
Disclosures
Robert Sidbury, MD, MPH
- Grant/Research Support: Site Investigator for Regeneron (Dupilumab for AD), Scioderm (Zublisa for EB)
- Advisory Committees or Review Panels: Advisory Board x1 for Pfizer regarding Crisaboroic for AD
Available Credit
- 1.00 Contact hours
- 1.00 Pharmacology hours at the advanced practice level
Price
Cost:
$20.00
Please login or create account to take this course.